Recently released market study: Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2013.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Full Report Details at
* A snapshot of the global therapeutic scenario for Hematopoietic Stem Cell Transplantation.
* A review of the Hematopoietic Stem Cell Transplantation products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Hematopoietic Stem Cell Transplantation pipeline on the basis of route of administration and molecule type.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.
Reasons to Get this Report
* Identify and understand important and diverse types of therapeutics under development for Hematopoietic Stem Cell Transplantation.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Hematopoietic Stem Cell Transplantation pipeline depth and focus of Indication therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.
Companies Mentioned in this Report: Hospira, Inc., Athersys, Inc., GlaxoSmithKline plc, BioLineRx, Ltd., Celldex Therapeutics, Inc., Antisense Therapeutics Limited, Actinium Pharmaceuticals, Inc., Pharmalink AB, Polyphor Ltd., Kiadis Pharma B.V., Bellicum Pharmaceuticals, Inc., TaiGen Biotechnology Co., Ltd., TikoMed AB
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.
For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
You may also be interested in these related reports:
- Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2013
- Myeloproliferative Disorders - Pipeline Review, H2 2012
- Transplantation - Pipeline Review, H2 2013
- Plasma Cell Neoplasm - Pipeline Review, H2 2012
- Bone Marrow Transplantation - Pipeline Review, H2 2013
Copyright 2013 UKPRwire
Provided by Syndigate.info an Albawaba.com company
|Printer friendly Cite/link Email Feedback|
|Date:||Oct 18, 2013|
|Previous Article:||Recent Study: Greece Defence & Security Report Q4 2013.|
|Next Article:||New Market Research Report: Stomatitis (Sore Mouth) Global Clinical Trials Review, H2, 2013.|